dm+d
Unassigned
New Medicines
Radiation-induced oral mucositis
Information
New molecular entity
Galera Therapeutics
Galera Therapeutics
Development and Regulatory status
None
None
Phase III Clinical Trials
Category
First-in-class, small-molecule that mimics the activity of the superoxide dismutase enzyme family
97% of all patients receiving radiotherapy (with or without chemotherapy) for head and neck cancers will suffer from some degree of OM [1].
Radiation-induced oral mucositis
Intravenous infusion